{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:41:51Z","timestamp":1773283311166,"version":"3.50.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T00:00:00Z","timestamp":1371772800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0066708","type":"journal-article","created":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T21:11:43Z","timestamp":1371849103000},"page":"e66708","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Calcium Antagonists Use and Its Association with Lower Urinary Tract Symptoms: A Cross-Sectional Study"],"prefix":"10.1371","volume":"8","author":[{"given":"Elsamaul S.","family":"Elhebir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery D.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha C.","family":"Hilmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,6,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.eururo.2008.03.109","article-title":"Lower urinary tract symptoms revisited: a broader clinical perspective","volume":"54","author":"CR Chapple","year":"2008","journal-title":"Eur Urol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1464-410X.2003.04961.x","article-title":"How is the lower urinary tract affected by gynaecological surgery?","volume":"94","author":"K Walsh","year":"2004","journal-title":"BJU Int"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1152\/physrev.00038.2003","article-title":"Urinary Bladder Contraction and Relaxation: Physiology and Pathophysiology","volume":"84","author":"K Andersson","year":"2004","journal-title":"Physiol Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.bjp.0702640","article-title":"The contribution of intracellular Ca2+ release to contraction in human bladder smooth muscle","volume":"127","author":"JG Masters","year":"1999","journal-title":"Br J Pharmacol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00210-007-0208-0","article-title":"Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and beta-adrenoceptors","volume":"377","author":"EP Frazier","year":"2008","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1096\/fj.04-1516fje","article-title":"An essential role of Cav1.2 L-type calcium channel for urinary bladder function","volume":"18","author":"JW Wegener","year":"2004","journal-title":"FASEB J"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Young MA, Watson RDS, Stallard TJ, Littler WA (1985) Calcium channel blockers\u2013are they diuretics? Br J Clin Pharmacol 20.","DOI":"10.1111\/j.1365-2125.1985.tb05149.x"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1620\/tjem.166.135","article-title":"The diuretic effect of calcium entry blockade in normals and hypertensive patients","volume":"166","author":"GG Geyskes","year":"1992","journal-title":"Tohoku J Exp Med"},{"key":"ref9","unstructured":"Antonelli D, Koltun B (1984) Excessive nifedipine diuretic effect. Br Med J 288."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2165\/00003495-198500292-00006","article-title":"Hemodynamic, hormonal, and diuretic effects of felodipine in healthy normotensive volunteers","volume":"29","author":"HE Sluiter","year":"1985","journal-title":"Drugs"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.HYP.10.6.577","article-title":"Repetitive natriuresis and blood pressure. Long-term calcium entry blockade with isradipine","volume":"10","author":"LR Krusell","year":"1987","journal-title":"Hypertension"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1532-5415.1993.tb06463.x","article-title":"Constipation in the elderly","volume":"41","author":"D Harari","year":"1993","journal-title":"J Am Geriatr Soc"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1046\/j.1464-410x.1999.00397.x","article-title":"The pharmacological treatment of urinary incontinence","volume":"84","author":"KE Andersson","year":"1999","journal-title":"Br J Urol"},{"key":"ref14","first-page":"899","article-title":"Experimental study on the action of diltiazem on detrusor muscle and clinical evaluation in patients with detrusor hyperactivity","volume":"39","author":"S Faustini","year":"1989","journal-title":"Arzneimittelforschung"},{"key":"ref15","first-page":"486","article-title":"Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. A placebo controlled, randomized clinical test","volume":"48","author":"G Frohlich","year":"1998","journal-title":"Arzneimittelforschung"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0022-5347(17)40635-5","article-title":"Effects of intravesical instillation of verapamil in patients with detrusor hyperactivity","volume":"141","author":"A Mattiasson","year":"1989","journal-title":"J Urol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0022-5347(01)69090-6","article-title":"A randomized, double-blind, placebo controlled crossover trial of nimodipine in older persons with detrusor instability and urge incontinence","volume":"167","author":"G Naglie","year":"2002","journal-title":"J Urol"},{"key":"ref18","first-page":"223","article-title":"Calcium channel blocker associated lower urinary tract symptoms in males: an Australian retrospective observational study","volume":"19","author":"JD Hughes","year":"2011","journal-title":"Qual Prim Care"},{"key":"ref19","unstructured":"(2006) AUA Guideline on the management of benign prostatic hyperplasia: diagnosis and treatment recommendations. In: American Urological Association, editor."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0090-4295(01)01487-X","article-title":"Questionnaire analysis on sex difference in lower urinary tract symptoms","volume":"59","author":"HH Kakizaki","year":"2002","journal-title":"Urology"},{"key":"ref21","unstructured":"Chancellor MB, Rivas DA (1993) American Urological Association symptom index for women with voiding symptoms: lack of index specificity for benign prostate hyperplasia. J Urol 150: 1706\u20131708; discussion 1708\u20131709."},{"key":"ref22","unstructured":"Australian Government: Department of Health and Ageing (2009) Australian statistics on medicines 2008. Canberra (Australia). 74\u201375 p."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1442-2042.1997.tb00138.x","article-title":"Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the international prostate symptom score","volume":"4","author":"Y Homma","year":"1997","journal-title":"Int J Urol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"DE Irwin","year":"2006","journal-title":"Eur Urol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.urology.2003.09.070","article-title":"Comparative analysis of lower urinary tract symptoms and bother in both sexes","volume":"63","author":"AA Terai","year":"2004","journal-title":"Urology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5694\/j.1326-5377.1997.tb138783.x","article-title":"Troublesome lower urinary tract symptoms in the community: a prevalence study","volume":"167","author":"CB Pinnock","year":"1997","journal-title":"Med J Aust"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1445-5994.2001.00035.x","article-title":"Urinary symptoms and incontinence in an urban community: prevalence and associated factors in older men and women","volume":"31","author":"DJ Muscatello","year":"2001","journal-title":"Intern Med J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1097\/01.ju.0000092942.87643.27","article-title":"Lower Urinary Tract Symptoms in Men and Women Without Underlying Disease Causing Micturition Disorder: A Cross-Sectional Study Assessing the Natural History of Bladder Function","volume":"170","author":"I Araki","year":"2003","journal-title":"J Urol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1464-410X.2003.04369.x","article-title":"The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study","volume":"92","author":"P Boyle","year":"2003","journal-title":"BJU Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1742-1241.2007.01508.x","article-title":"Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting","volume":"61","author":"MJ Naslund","year":"2007","journal-title":"Int J Clin Pract"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1464-410X.1994.tb09181.x","article-title":"'Prostate-related symptoms' in Canadian men 50 years of age or older: prevalence and relationships among symptoms","volume":"74","author":"RW Norman","year":"1994","journal-title":"Br J Urol"},{"key":"ref32","first-page":"22267","article-title":"IPSS is lower in hypertensive patients treated with angiotensin-II receptor blocker: Posthoc analyses of a lower urinary tract symptoms population","volume":"12","author":"H Ito","year":"2012","journal-title":"Neurourol Urodyn"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/j.1464-410X.2011.10593.x","article-title":"Commonly used antihypertensives and lower urinary tract symptoms: results from the Boston Area Community Health (BACH) Survey","volume":"109","author":"SA Hall","year":"2012","journal-title":"BJU Int"},{"key":"ref34","first-page":"15","article-title":"Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine","volume":"46","author":"L Guarneri","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0140-6736(86)91127-X","article-title":"Nifedipine and nocturia","volume":"1","author":"G Williams","year":"1986","journal-title":"Lancet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0066708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T23:19:38Z","timestamp":1595978378000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0066708"}},"subtitle":[],"editor":[{"given":"Praveen","family":"Thumbikat","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,21]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0066708","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,21]]}}}